Registered Uganda · NDA

DOLUTEGRAVIR + LAMIVUDINE

NDA/MAL/HDP/11157 ORAL SOLID ORDINARY FILM-COATED TABLETS 50 MG + 300 MG

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
NDA/MAL/HDP/11157
Registration date
02/02/2024
Expiry date
-
Status
Registered
Active ingredient
-
Dosage form
ORAL SOLID ORDINARY FILM-COATED TABLETS
Strength
50 MG + 300 MG
Pack size
1.0X1.0X30.0 TABLET BOTTLE
Therapeutic class
-
Manufacturer / MAH
Glaxosmithkline, LLC
Applicant / LTR
GLAXOSMITHKLINE PHARMACEUTICAL KENYA LTD
Country of origin
UNITED STATES
Manufacturer location
1011 N Arendell Ave, Zebulon, NC 27597, USA

Source: National Drug Authority · fetched 2026-04-21 17:37:05 · updated 2026-09-12 04:00:20

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.